发明名称 Trans-viral vector mediated gene transfer to the retina
摘要 Methods and compositions for the delivery and expression of a nucleotide sequence of interest to a cell of a mammalian eye, more particularly to a cell of the retina, more particularly to the retinal pigment epithelium (RPE) are provided. The methods and compositions of the present invention find use in modulating the expression of a nucleotide sequence of interest in a cell of a mammalian eye using the trans-viral vector system. The methods and compositions of the present invention find further use in the treatment and/or prevention of ocular disorders, particularly retinal degenerative disorders. The methods comprise administering to a retinal cell of a mammal in need thereof, a therapeutically effective amount of a trans-viral vector particle having a proviral genome comprising a nucleotide sequence of interest whose expression will lessen the clinical symptoms of the retinal disorder being treated.
申请公布号 US2003003582(A1) 申请公布日期 2003.01.02
申请号 US20020140227 申请日期 2002.05.07
申请人 TRANZYME, INC. 发明人 WAKEFIELD JOHN;BENNETT JEAN
分类号 A61K48/00;C12N15/867;(IPC1-7):A61K48/00 主分类号 A61K48/00
代理机构 代理人
主权项
地址